Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. Akiyama H, Kantarjian H, Jabbour E, Issa G, et al. Int J Hematol 2024 May 15. doi: 10.1007/s12185-024-03787.

Read + Share

Amedeo Smart

Independent Medical Education

Akiyama H, Kantarjian H, Jabbour E, Issa G, et al. Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. Int J Hematol 2024 May 15. doi: 10.1007/s12185-024-03787.
PMID: 38748089